On the mechanisms of biocompatibility.

https://journal.chestnet.org/article/S0012-3692(12)60137-8/pdf

Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Cells can respond to stress in various ways ranging from the activation of survival pathways to the initiation of cell death that eventually eliminates damaged cells. Whether cells mount a protective or destructive stress response depends to a large extent on the nature and duration of the stress as well as the cell type. Also, there is often the interplay between these responses that ultimately determines the fate of the stressed cell. The mechanism by which a cell dies (i.e., apoptosis, necrosis, pyroptosis, or autophagic cell death) depends on various exogenous factors as well as the cell's ability to handle the stress to which it is exposed. The implications of cellular stress responses to human physiology and diseases are manifold and will be discussed in this review in the context of some major world health issues such as diabetes, Parkinson's disease, myocardial infarction, and cancer.

/pdf/cellular-stress-responses-cell-survival-and-cell-death-ucpcetstfo.pdf

Cellular Stress Responses: Cell Survival and Cell Death

Publisher Summary This chapter discusses the chemistry, metabolism, and biological functions of sialic acids. Interest in the sialic acids has rapidly increased in recent years, especially because of the reorganization of their involvement in the regulation of a great variety of biological phenomena. The occurrence of sialic acids in plants has never unequivocally been established, although some positive reports exist. The acylneuraminic acids can be released from their glycosidic linkages either by dilute (aqueous or methanolic) acids or sialidases. The unequivocal determination of sialic acids occurring in low concentrations in many biological materials is rather difficult, and this explains the many errors that have been made in this field. The biosynthesis of N-acetylneuraminic acid (Neu5Ac) is briefly reported in this chapter and more attention is given to the enzyme reactions modifying this compound. Little information is available about the role of the modifications of sialic acid resulting in a species- and tissue-specific distribution of different N,O-acylated and O-methylated sialic acids.

Chemistry, Metabolism, and Biological Functions of Sialic Acids

https://journal.chestnet.org/article/S0012-3692(12)60118-4/pdf

Parenteral Anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Protamine is unable to completely reverse the anticoagulant effect of the low-molecular-weight heparins (LMWH), a fact of clinical importance given the rapid increase in use of LMWH in clinical practice. This investigation sought to determine the mechanism by which LMWH were able to resist protamine-mediated inactivation. Affinity fractionation of LMWH by passage through a protamine column, with subsequent determination of molecular mass and sulphate charge density, demonstrated that the protamine-resistant fraction in LMWH is an ultra-low-molecular-weight fraction with low sulphate charge density. This group of molecules was not found in unfractionated heparin, even when species of similar molecular mass were compared. We then determined that different commercially available LMWH varied in their ability to be neutralized by protamine, and that this variability correlated with the total sulphate content of the LMWH. We conclude that reduced sulphate charge, not molecular mass, is the principle reason that protamine is unable to fully inactivate LMWH. Furthermore, different LMWH vary in their ability to be neutralized by protamine, suggesting that product-specific recommendations for neutralization might be developed.

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2141.2002.03233.x

Mechanisms responsible for the failure of protamine to inactivate low-molecular-weight heparin.

Inhibition of thrombin by antithrombin III in the presence of certain glycosaminoglycans found in the mammalian aorta.

Age-related differences in heparin response

Human transferrin consists of a single chain polypeptide which supports two N-glycosidically linked glycans at sequons a and b. Glycopeptides were released from human transferrin by proteolytic digestion, desialylated by mild acid hydrolysis, and then isolated by chromatographic methods. The structures of the glycans located on each sequon were determined by a combination of analytical techniques including Smith degradation, permethylation, and enzymic degradation. Approximately 79% of the total glycan from sequon a was of the biantennary type as previously described by Dorland and his colleagues (FEBS Lett. 77, 15-20 (1977)). The remaining 21% consisted of a mixture of triantennary and tetraantennary glycans, each amounting to approximately 10% of the total glycan for this sequon. The triantennary structure resembled that described for the N-glycosidic triantennary glycans of bovine fetuin by Nilsson and his colleagues (J. Biol. Chem. 254, 4545-4553 (1979)). Of the tetraantennary glycan, approximately half of the structures were incomplete, i.e., one antenna terminated by N-acetylglucosamine. On sequon b, 81% of the glycan was biantennary, identical to those biantennary glycans of sequon a, and the reminder was triantennary, also of the fetuin type. The glycan structures and their locations on the polypeptide are related to the known subpopulations of human transferrin.

The structural heterogeneity of the carbohydrate moiety of desialylated human transferrin.

Highly anticoagulant covalent antithrombin-heparin complex (ATH) was covalently grafted onto polyurethane catheters to suppress adsorption/activation of procoagulant proteins and enhance adsorption/activation of anticoagulant proteins for blood compatibility. Consistency of catheter coating was demonstrated using immunohistochemical visualization of ATH. The ability of the resulting immobilized ATH heparin chains to bind antithrombin (AT) from plasma, as measured by binding of 125I-radiolabeled AT, was greater than that for commercially-available heparin-coated catheters, and much greater than for uncoated catheters. Complementary measurements of antifactor Xa (FXa) activity and plasma protein binding were also performed. Both ATH-coated and heparin-coated catheters demonstrated functional binding of exogenous AT. However, the ATH-coated catheters gave a trend towards elevated anti- FXa activities/AT binding ratios, consistent with the higher active pentasaccharide content in starting ATH. Western blot analysis of proteins adsorbed to catheters after incubation with rabbit plasma established protein binding profiles that showed AT and albumin as major plasma proteins adsorbed to ATH-coated catheters, while AT and altered forms of fibrinogen were major plasma protein species adsorbed to heparinized catheters. © 2006 Wiley Periodicals, Inc. J Biomed Mater Res, 2007

Leslie R. Berry

Papers

Mechanisms responsible for the failure of protamine to inactivate low-molecular-weight heparin.

Inhibition of thrombin by antithrombin III in the presence of certain glycosaminoglycans found in the mammalian aorta.

Age-related differences in heparin response

The structural heterogeneity of the carbohydrate moiety of desialylated human transferrin.

Protein adsorption on polyurethane catheters modified with a novel antithrombin-heparin covalent complex.